Showing results (1-10 of 98) with videos related to

Sort By:
Pageof 10
Clinical Pharmacokinetics|February 21, 2012
Clinical pharmacokinetics and pharmacodynamics of vildagliptinYan-Ling He
The Journal of Dermatological Treatment|July 12, 2019
Efficacy and safety of imiquimod 5% cream for basal cell carcinoma: a meta-analysis of randomized controlled trialHong-Xia Jia, Yan-Ling He
British Journal of Clinical Pharmacology|March 24, 2012
Mechanism-based population pharmacokinetic modelling in diabetes: vildagliptin as a tight binding inhibitor and substrate of dipeptidyl peptidase IVCornelia B Landersdorfer, Yan-Ling He, William J Jusko
British Journal of Clinical Pharmacology|March 24, 2012
Mechanism-based population modelling of the effects of vildagliptin on GLP-1, glucose and insulin in patients with type 2 diabetesCornelia B Landersdorfer, Yan-Ling He, William J Jusko
Zhonghua Yi Xue Za Zhi|January 13, 2011
[Survey on the prevalence of anxiety disorders in internal medical outpatients at general hospital]Li Mei, Ze-ping Xiao, Yan-ling He, et al.
Biotechnology Letters|September 1, 2006
The settling characteristics and mean settling velocity of granular sludge in upflow anaerobic sludge blanket (UASB)-like reactorsYong-Hong Liu, Yan-Ling He, Shu-Cheng Yang, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|May 11, 2010
[Clinical analysis of 355 patients with bone metastasis of malignant tumors]Nan-nan Liu, Dong-lan Shen, Xiao-qiu Chen, et al.
Pageof 10